Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?

The discordance between pre-clinical success and clinical failure of treatment options for Duchenne Muscular Dystrophy (DMD) is significant. The termination of clinical trials investigating the phosphodiesterase inhibitors, sildenafil and tadalafil (which prolong the second messenger molecule of nit...

Full description

Bibliographic Details
Main Authors: Cara A. Timpani, Kamel Mamchaoui, Gillian Butler-Browne, Emma Rybalka
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/9/12/1268